NASDAQ: DRMADermata Therapeutics Inc Stock Ownership - Who owns Dermata Therapeutics?
Insider buying vs selling
Have Dermata Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when DRMA insiders and whales buy or sell their stock.
DRMA Shareholders
What type of owners hold Dermata Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gerald T. Proehl | 47.75% | 3,180,465 | $1.12M | Insider |
| Proehl Investment Ventures LLC | 43.62% | 2,905,544 | $1.02M | Insider |
| David F. Hale | 13.86% | 923,383 | $324.11k | Insider |
| Armistice Capital LLC | 3.27% | 218,000 | $76.52k | Institution |
| Munera Maria E. Bedoyatoro | 1.72% | 114,630 | $40.24k | Insider |
| Wendell Wierenga | 0.94% | 62,398 | $21.90k | Insider |
| Acadian Asset Management LLC | 0.83% | 55,179 | $19.37k | Institution |
| Kathleen D. Scott | 0.44% | 29,584 | $10.38k | Insider |
| Christopher J. Nardo | 0.41% | 27,560 | $9.67k | Insider |
| Andrew Seth Sandler | 0.36% | 24,184 | $8.49k | Insider |
DRMA vs Biotech Stocks
Dermata Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.